Whitehawk Therapeutics (WHWK) Interest Expenses (2010 - 2026)

Whitehawk Therapeutics (WHWK) has 17 years of Interest Expenses data on file, last reported at $8.1 million in Q1 2026.

• On a quarterly basis, Interest Expenses rose 8050.51% year-over-year to $8.1 million in Q1 2026; TTM through Mar 2026 was $8.1 million, a 1008.38% increase from a year earlier, with the FY2025 full-year figure at $3.2 million, down 97.37% from the prior year.
• Interest Expenses for Q1 2026 stood at $8.1 million, up from -$99000.0 in the prior quarter.
• Over the last five years, Interest Expenses for WHWK reached as high as $8.1 million in Q1 2026 and fell as low as -$99000.0 in Q4 2025.
• Historically, Interest Expenses has averaged $992000.0 across 5 years, with a median of $280000.0 in 2024.
• Across the five-year window, Interest Expenses plunged 122.2% in 2025 and surged 8050.51% in 2026, its largest moves.
• Year by year, Interest Expenses stood at $57000.0 in 2022, then changed by 0.0% to $57000.0 in 2023, then soared by 682.46% to $446000.0 in 2024, then plunged by 122.2% to -$99000.0 in 2025, then surged by 8250.51% to $8.1 million in 2026.
• Per Business Quant data, the three most recent Interest Expenses figures were $8.1 million in Q1 2026, -$99000.0 in Q4 2025, and $539000.0 in Q3 2025.